Track the Jupiter Wellness Acquisition Corp. share price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Jupiter Wellness Acquisition Corp. has logged 4 reports. The latest transaction was disclosed on 17 March 2022 (J). Among the most active insiders: John Brian. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
Jupiter Wellness Acquisition Corp. is a U.S.-listed special purpose acquisition company (SPAC) rather than a traditional operating business. The company was incorporated in Delaware on September 14, 2021, and was formed to pursue a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more target companies. SEC filings and related market disclosures show that its principal executive offices are located at 1061 E. Indiantown Road, Suite 110, Jupiter, Florida 33477, in the United States. The company came to market through a 2021 initial public offering and, at launch, stated an investment focus on healthcare-related targets, including healthcare AI, medical therapeutics, and diagnostics. That healthcare emphasis is the main reason the company is best categorized under Health & Pharma for francophone investors, even though as a SPAC it does not itself sell branded drugs, devices, or consumer health products. From a competitive standpoint, Jupiter Wellness Acquisition Corp.’s ‘business’ is deal sourcing rather than product execution. Its value proposition depends on management’s ability to identify, negotiate, and complete a transaction with an attractive private company, ideally in a sector where the sponsor believes it has relevant expertise. That makes the company fundamentally different from an industrial or commercial issuer: there is no stable operating footprint, no recurring product revenue, and no direct competitive share in a product market prior to a de-SPAC transaction. In terms of recent milestones, the key corporate event was the announced business combination with Chijet, a China-based automotive group, which was approved by stockholders and closed on June 1, 2023. That transaction materially changed the trajectory of the vehicle associated with the original SPAC structure. For investors looking at SEC Form 4 insider activity, the important analytical point is that post-merger ownership and governance dynamics may differ substantially from the original SPAC framework, so filings should be read in the context of the company’s current post-combination structure. Overall, Jupiter Wellness Acquisition Corp. should be viewed as a U.S. capital-markets vehicle associated with the NASDAQ/NYSE ecosystem in the United States, with a history rooted in healthcare-focused SPAC sponsorship and a recent transformation through its completed business combination.